Inhibikase Therapeutics (IKT)
(Delayed Data from NSDQ)
$1.39 USD
+0.05 (3.73%)
Updated Sep 9, 2024 03:59 PM ET
After-Market: $1.39 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Earnings News For IKT
-
Inhibikase Therapeutics Reports Second Quarter Financial Results and Highlights Recent Period Activity
-
Inhibikase Therapeutics Reports First Quarter Financial Results and Highlights Recent Period Activity
-
Inhibikase Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Activity
-
Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Period Activity
-
Inhibikase Therapeutics Reports Second Quarter Financial Results and Highlights Recent Period Activity
-
Inhibikase Therapeutics Reports First Quarter Financial Results and Highlights Recent Period Activity
-
Inhibikase Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Recent Period Activity